相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
Falk Hiepe et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
Ian J. Amanna et al.
IMMUNOLOGICAL REVIEWS (2010)
Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation
Y. K. O. Teng et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies
Y. K. O. Teng et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
Maria Rehnberg et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Proteasome inhibition as a novel therapy in treating rheumatoid arthritis
Jan Brun
MEDICAL HYPOTHESES (2008)
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
Sanna Rosengren et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment
Y. K. Onno Teng et al.
ARTHRITIS AND RHEUMATISM (2007)
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis
Edward Keystone et al.
ARTHRITIS AND RHEUMATISM (2007)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy
M. Bokarewa et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells
Jacob M. van Laar et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis
E. Toubi et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response
K. N. Verpoort et al.
ARTHRITIS AND RHEUMATISM (2006)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
P Emery et al.
ARTHRITIS AND RHEUMATISM (2006)
Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment - Relationships with B cell depletion, circulating antibodies, and clinical relapse
G Cambridge et al.
ARTHRITIS AND RHEUMATISM (2006)
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis:: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
AHM van der Helm-van Mil et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Drug therapy - Therapeutic strategies for rheumatoid arthritis
JR O'Dell
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice
BF Hoyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities
L Colomo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
G Cambridge et al.
ARTHRITIS AND RHEUMATISM (2003)
Maintenance of serological memory by polyclonal activation of human memory B cells
NL Bernasconi et al.
SCIENCE (2002)
Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells
WJE Van Esch et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
分享论文
